A medical degree or a minimum of an upper second-class UK Bachelor’s degree in biomedical science, or another relevant discipline, or an overseas qualification of an equivalent standard.If your education has not been conducted in the English language, you will be expected to demonstrate evidence of a good level of English proficiency. If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency. The English language level for this programme is: Good. Further information can be found on our English language requirements http://www.ucl.ac.uk/prospective-students/graduate/life/international/english-requirements page.
Months of entry
This unique programme builds on the recent successes in clinical applications of immunotherapy for a range of immune-mediated diseases and#8211; for example, the use of anti-TNF therapies in rheumatoid arthritis patients and#8211; and, drawing on faculty-wide expertise, focuses on the processes involved in translating immunobiology research, using the eye as a model.
UCL is the largest centre for biomedical research in the UK and offers unique opportunities to study applied immunobiology.
The UCL Institute of Ophthalmology is an international leader in translational research and clinical and industrial collaborations are in place. UCL academics who advise on the research methodology involved in successful translational projects and#8211; study design, applications for ethics approval, funding applications, peer-review publications, data presentation and writing skills and#8211; will provide case studies, presentations and seminars.
The eye is an excellent model for monitoring disease activity, responses to therapy, and clinical scoring, and is an ideal organ for delivering new therapies.
Full-time: 1 year;
Qualification and course duration
Course contact details
- +44 (0)20 3370 1214